Molecular Detection of Advanced Neoplasia in Pancreatic Cysts

Description

Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.

Conditions

Pancreas Cyst

Talk to us

Study Overview

On this page

Study Details

Study overview

Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.

Molecular Detection of Advanced Neoplasia in Pancreatic Cysts (IN-CYST)

Molecular Detection of Advanced Neoplasia in Pancreatic Cysts

Condition
Pancreas Cyst
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients with pancreatic cystic lesions meeting Fukuoka worrisome or Fukuoka high-risk criteris
  • * Patients with suspected cystic neoplasm of the pancreas
  • * Able to provide written informed consent
  • * Pregnant and/or nursing
  • * Incarceration
  • * Imaging showing possible pancreatic cancer
  • * Prior history of pancreatic cancer or pancreatic surgery
  • * History of receiving systemic chemotherapy or abdominal radiation within the last 5 years
  • * Previous therapy for a pancreatic cystic lesion
  • * History of pancreatic necrosis
  • * Diagnosis of cancer (other than non-melanoma skin cancer) within the last 5 years

Ages Eligible for Study

18 Years to 120 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Shounak Majumder, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2030-12-30